Mark Cuban Says 'We Will Always Pay More' as PBMs Set Drug Prices, Calls Healthcare Conglomerates 'Too Big to Care'
Mark Cuban says PBMs are the reason for high brand-name drug prices in the US. His company could offer lower prices if allowed to sell them.
Mark Cuban says middlemen called PBMs control drug prices and make them expensive, and his company could offer cheaper options if rules allowed it. When a successful businessman complains about a system being unfair, it's worth noticing—it hints there might be real problems worth understanding.
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.